Paper40104641
Ultrasound-responsive engineered bacteria mediated specific controlled expression of catalase and efficient radiotherapy.
Liu Z and 4 others. Mater Today Bio, 2025. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Ultrasound-responsive engineered bacteria mediated specific controlled expression of catalase and efficient radiotherapy. Papers, record 40104641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40104641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ultrasound-responsive engineered bacteria mediated specific controlled expression of catalase and efficient radiotherapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37572455 | Cellular and exosomal GPx1 are essential for controlling hydrogen peroxide balance and alleviating oxidative stress in hypoxic glioblastoma. | Redox Biol | 2023 | https://conductscience.org/library/papers/37572455 | PubMed |
| 2 | 27840167 | Drug-induced co-assembly of albumin/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy. | J Control Release | 2017 | https://conductscience.org/library/papers/27840167 | PubMed |
| 3 | 38640931 | Ultrasound-visible engineered bacteria for tumor chemo-immunotherapy. | Cell Rep Med | 2024 | https://conductscience.org/library/papers/38640931 | PubMed |
| 4 | 17593909 | A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. | Mol Syst Biol | 2007 | https://conductscience.org/library/papers/17593909 | PubMed |
| 5 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 6 | 12790676 | Ultrasound increases the rate of bacterial cell growth. | Biotechnol Prog | 2003 | https://conductscience.org/library/papers/12790676 | PubMed |
| 7 | 33605723 | Novel Engineered Bacterium/Black Phosphorus Quantum Dot Hybrid System for Hypoxic Tumor Targeting and Efficient Photodynamic Therapy. | ACS Appl Mater Interfaces | 2021 | https://conductscience.org/library/papers/33605723 | PubMed |
| 8 | 36917948 | The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36917948 | PubMed |
| 9 | 26996613 | Metabolic Burden: Cornerstones in Synthetic Biology and Metabolic Engineering Applications. | Trends Biotechnol | 2016 | https://conductscience.org/library/papers/26996613 | PubMed |
| 10 | 20944664 | Engineering the perfect (bacterial) cancer therapy. | Nat Rev Cancer | 2010 | https://conductscience.org/library/papers/20944664 | PubMed |
| 11 | 29558152 | Bacteria-Mediated Tumor Therapy Utilizing Photothermally-Controlled TNF-α Expression via Oral Administration. | Nano Lett | 2018 | https://conductscience.org/library/papers/29558152 | PubMed |
| 12 | 25881030 | Critical aspects of using bacterial cell viability assays with the fluorophores SYTO9 and propidium iodide. | BMC Microbiol | 2015 | https://conductscience.org/library/papers/25881030 | PubMed |
| 13 | 33854892 | Bacteria-Based Cancer Immunotherapy. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/33854892 | PubMed |
| 14 | 27532320 | Carbon-Dot-Decorated Carbon Nitride Nanoparticles for Enhanced Photodynamic Therapy against Hypoxic Tumor via Water Splitting. | ACS Nano | 2016 | https://conductscience.org/library/papers/27532320 | PubMed |
| 15 | 38486983 | Towards overcoming obstacles of type II photodynamic therapy: Endogenous production of light, photosensitizer, and oxygen. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/38486983 | PubMed |
| 16 | 38610042 | Bacteria-driven nanosonosensitizer delivery system for enhanced breast cancer treatment through sonodynamic therapy-induced immunogenic cell death. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/38610042 | PubMed |
| 17 | 30837696 | Engineering advanced cancer therapies with synthetic biology. | Nat Rev Cancer | 2019 | https://conductscience.org/library/papers/30837696 | PubMed |
| 18 | 39395706 | Multi-functional nanosonosensitizer-engineered bacteria to overcome tumor hypoxia for enhanced sonodynamic therapy. | Acta Biomater | 2024 | https://conductscience.org/library/papers/39395706 | PubMed |
| 19 | 9278503 | The complete genome sequence of Escherichia coli K-12. | Science | 1997 | https://conductscience.org/library/papers/9278503 | PubMed |
| 20 | 37504889 | In situ hypoxia modulating nano-catalase for amplifying DNA damage in radiation resistive colon tumors. | Biomater Sci | 2023 | https://conductscience.org/library/papers/37504889 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953313 | Engineered Metal-Organic Frameworks for Sonodynamic Therapy: from Coordination Chemistry to Acoustic-ROS Transduction. | Precis Chem | 2026 | https://conductscience.org/library/papers/42953313 | PubMed |
| 42582682 | From Mechanism to Clinic: Engineered Bacteria-Nanomaterial Hybrid Systems for Cancer Immunotherapy. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/42582682 | PubMed |
| 42557511 | Ultrasound-targeted cavitation induced tumor vascular normalization and radiotherapy sensitization in breast cancer. | Sci China Life Sci | 2026 | https://conductscience.org/library/papers/42557511 | PubMed |
| 42197350 | The Use of Bacteria and Their Toxins as Antitumor Agents: Present and Future. | Microorganisms | 2026 | https://conductscience.org/library/papers/42197350 | PubMed |
| 41928245 | Photoactivated probiotic micro-reactor synchronizes STING/TLRs agonists to spatiotemporally synergize antitumor immunotherapy. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41928245 | PubMed |
| 41764403 | Ultrasound-Responsive Engineered Bacteria for Targeted Cancer Therapy: Strategies, Mechanisms, and Applications. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41764403 | PubMed |
| 41698062 | Attenuated Bacteria-Based Tumor Therapy: Clinical Application Risks, Marketing Approval Restrictions, and Coping Strategies. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41698062 | PubMed |
| 41660120 | A paradigm shift from penetration: Material-based solutions for multidimensional spatiotemporal, hypoxic, and optical challenges in cutaneous photodynamic therapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41660120 | PubMed |
| 41560786 | Cartilage organoids bridging bench to bedside: A steroid-free strategy for early osteoarthritis repair. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41560786 | PubMed |
| 40155884 | Dual-pathway tumor radiosensitization strategy based on engineered bacteria capable of targeted delivery of AuNPs and specific hypoxia alleviation. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40155884 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CAT | 847 | PubTator's text mining | https://conductscience.org/library/genes/847 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40104641
GET https://conductscience.org/api/papers/v1/40104641/references?page=2